Advertisement

Hematology and Oncology

Home Hematology and Oncology
Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.

FDA Approves ‘Biosimilar’ Drug to Treat Certain Types of Anemia

Retacrit is biosimilar to the drugs Epogen and Procrit
Teledermatology for suspected skin cancer is slightly more expensive than usual care

Teledermatology Could Expedite Care for Suspected Skin Cancer

Australian study finds implementation significantly speeds time to clinical resolution
Moderate wine consumption does not seem to impact the risk of prostate cancer

Overall, Drinking Wine Does Not Impact Prostate Cancer Risk

Findings show small increased risk with white wine, decreased risk with red wine
Four lung cancer risk models perform best in selecting ever-smokers for screening

Risk Models Help Select Ever Smokers for Lung CA Screening

Four models were well-calibrated and had higher AUCs than five that overestimated risk
Cytoskeleton-associated protein 4 appears to be a novel serodiagnostic marker for lung cancer

CKAP4 Is Novel Serodiagnostic Marker for Lung Cancer

Serum CKAP4 levels of lung cancer patients significantly higher than those of healthy controls
Screening blood donations for Zika virus in the United States is costly with low yield

Screening Blood Donations for Zika Virus Is Costly, Low Yield

Nine donations were confirmed positive; six of these had travelled to ZIKV-active areas
The risk of nodal metastasis is five-fold greater for skin cancer on the vermilion lip versus the cutaneous lip

Nodal Metastasis Risk Up When Cancer Is Directly on the Lip

Five-fold greater risk of nodal metastasis in cutaneous squamous cell carcinoma of the vermilion lip
Many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable about its utility

Many Oncologists Discuss, Recommend Medical Marijuana

But majority of oncologists don't feel knowledgeable enough to make these recommendations
Patients receiving immunotherapy with antiprogrammed cell death protein-1 and antiprogrammed cell death ligand-1 monoclonal antibodies may develop uveal effusion

Uveal Effusion Reported After Initiation of Anti-PD-1, -PD-L1

Case series IDs three patients who developed uveal effusion within one to two months of initiating tx
The U.S. Food and Drug Administration has launched legal action to stop two stem cell clinics from providing unapproved treatments that have caused serious

FDA Targets Clinics Offering Unapproved Stem Cell Therapies

Clinics claim unapproved therapies can treat number of diseases and conditions, including ALS and cancer